Synergis Software to Host Drawing Management & Collaboration Panel with Leaders from Eversource, Hoosier, and Great River Energy
30.3.2022 15:21:00 EEST | Business Wire | Press release
Synergis Software, a global leader in engineering document management and workflow solutions, is hosting a free live panel for engineering, operations, and IT leaders who want to learn how to overcome drawing management and collaboration chaos and create a more resilient, adaptable, and secure utility.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220330005277/en/
Synergis Software to Host Drawing Management and Collaboration Panel with Leaders from Eversource, Hoosier, and Great River Energy. Engineering and IT experts from three Utilities come together for a live webinar to discuss the costs of drawing management chaos, their solutions, the business impact, and best practices. (Graphic: Business Wire)
The live 90-minute webinar will take place on Wednesday, April 6, 2022, at 2:00 p.m. EDT. The panel will be moderated by Scott Lamond, Vice President at Synergis Software with these guest panelists:
- Paul J. Melzen, P.E., Director, Eversource Substation Engineering & Design
- Blake Donley, Principal Systems Analyst, Great River Energy
- Bernie Voges, Senior Protection Engineer, Hoosier Energy
Discussion topics will include the advantages of a centralized platform for drawing management and collaboration, best practices, and lessons learned for implementation and user adoption. Attendees will gain insights that will help them:
- Align engineering, construction, field service, and operations
- Ensure fast access to the right version, day or night
- Eliminate expensive mistakes and outages
- Simplify collaboration and accelerate projects
- Capture tribal knowledge and secure digital assets
- Streamline compliance and drive standards
The live Q&A session will allow attendees to get their questions answered.
Register now to reserve your seat, and if you can't attend, register to receive a replay.
“Our utility customers know the hidden costs and inefficiencies of doing business without a centralized drawing management and collaboration solution that aligns engineering, field service, operations, and construction,” says Scott Lamond, vice president at Synergis Software. “With our Adept engineering document management solution, utilities will increase asset reliability, improve operational efficiency, reduce compliance and safety risk, and lower operating costs.”
Paul Melzen, director, Eversource substation engineering and design says, “In addition to configuration control, drawing management has become more and more critical to reliability and compliance. If the drawings don't represent what's in the field, it's just a human error trap."
“When the people in the field can’t find the correct drawing, it can result in more man-hours spent to resolve an issue, which can have a direct impact on our customers,” adds Melzen. “Moreover, if we're designing and bidding on a project using inaccurate drawings, we’re exposing ourselves to the risk of change orders from our engineering and construction contractors. Not only can these issues have significant cost impacts to the company, but they can also impact compliance, reliability and safety.”
Synergis Adept is a proven solution used by utility customers such as Con Edison, Northwestern Energy, San Diego Gas & Electric, Dominion Energy, Emera Companies, Lansing Board of Water and Light, California Water Authority, Platte River Authority, Turlock Irrigation District and more.
For further information on the webinar or to register, visit the event page event page. If you can't attend, register to receive the replay.
About Synergis Software
Synergis Software is a global leader in document management and workflow solutions and is the creator of Synergis Adept software. Adept serves more than 120,000 users across dozens of industries providing fast, centralized access to design and business documents in a secure, collaborative environment. Adept Integrator connects your enterprise applications so your data and business processes flow seamlessly across your entire IT infrastructure.
Named the customer service leader in the global engineering information management market by Frost & Sullivan and ranked in the Top 5 globally by Helpdesk International for three consecutive years, our commitment to clients is unwavering.
Founded in 1985, Synergis Technologies, LLC is headquartered in Bucks County, PA and is privately owned and funded.
About Eversource
Eversource (NYSE: ES), celebrated as a national leader for its corporate citizenship, is the #1 energy company in Newsweek’s list of America’s Most Responsible Companies for 2021 and recognized as one of America’s Most JUST Companies. The #1 energy efficiency provider in the nation, the company is empowering a clean energy future in the Northeast, with nationally recognized energy efficiency solutions and successful programs to integrate new clean energy resources like solar, offshore wind, electric vehicles, and battery storage, into the electric system.
About Great River Energy
Great River Energy (GRE) is wholesale power cooperative; our member-owners are 28 Minnesota electric distribution cooperatives. Individuals and businesses are members of those distribution cooperatives based on their geographic location.
As a Touchstone Energy Cooperative, GRE is a part of a nationwide alliance made of more than 750 electric cooperatives in 46 states.
About Hoosier Energy
Hoosier Energy serves 18-member electric cooperatives in central and southern Indiana and southeastern Illinois. Founded in 1949 and based in Bloomington, Indiana, Hoosier Energy is a generation and transmission electric cooperative providing wholesale power and services to member distribution cooperatives. Their portfolio includes coal, natural gas and renewable energy resources that deliver power through a nearly 1,700-mile transmission network.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220330005277/en/
Contact information
Scott Lamond
Vice President of Marketing
Email: scott.lamond@synergis.com
Phone: 215-302-3006
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Consortium Led by Axelspace Selected for Japan’s Space Strategy Fund Project “Technology to Enhance Capability of Next Generation Earth Observation Satellites”30.3.2026 02:35:00 EEST | Press release
Axelspace Corporation, Meisei Electric Co., Ltd., ANA HOLDINGS INC., and JIJ Inc. are pleased to announce that their jointly proposed technology development project has been selected for Japan Aerospace Exploration Agency (JAXA)’s Space Strategy Fund under the theme “Technology to Enhance Capability of Next Generation Earth Observation Satellites.” This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260323044518/en/ Conceptual Diagram of the project. Under this Space Strategy Fund initiative, spectrometers will be newly developed and demonstrated in orbit. In the future, the project envisions the establishment of a satellite constellation capable of observations at different times of the day. Project Summary (Planned) Technology Development Theme: Technology to Enhance Capability of Next Generation Earth Observation Satellites Project Title: Source-Specific CO2 Emission and Uptake Monitoring through Satellite Constellation and Ai
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 21:00:00 EET | Press release
Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham, MSc, MD, FRCPC, dermatologist, SKiN Centre for Dermatology, Peterborough, Ontario, Canada, principal investigator for the Latitude PsO studies and presenting author. “These efficacy and safety results show it’s possible for a once-daily pill to deliver rapid, lasting skin clearance, highlighting the potential of zasoc
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 21:00:00 EET | Press release
Incyte (Nasdaq:INCY) today announced 54-week data evaluating the safety and efficacy of povorcitinib (INCB54707), an oral small-molecule highly-selective JAK1 inhibitor, from the pivotal Phase 3 STOP-HS clinical trial program in adult patients (≥18 years) with moderate to severe hidradenitis suppurativa (HS). The late-breaking oral presentation of these data is taking place at the 2026 American Academy of Dermatology (AAD) Annual Meeting, being held March 27-31, 2026, in Denver (Session: S034 – Late-Breaking Research: Session 2. Saturday, March 28, 2026, 1:00-4:00 p.m. MT). “The 54-week results from the STOP-HS program deliver compelling, long-term evidence supporting the potential of povorcitinib for patients with moderate to severe HS,” said Pablo J. Cagnoni, M.D., President and Global Head of Research and Development, Incyte. “Across both studies, povorcitinib demonstrated substantial and durable improvements over time in key measures of treatment success and meaningful clinical ben
AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 17:00:00 EET | Press release
Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-breaking session at the 2026 American Academy of Dermatology (AAD) Annual Meeting. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260328320362/en/ Atopic dermatitis is the most common inflammatory skin disorder in children, yet treatment options in the moderate-to-severe pediatric setting are limited.5 The disease can have a significant impact on quality of life for both the patients and their loved ones, with persistent itch and recurrent skin lesions often disrupting sleep, school and relationships.5-8 “Atopic dermatitis can affect many aspects of children’s lives including schoolwork, emotional development
Angelalign Technology (6699.HK) Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 21:56:00 EET | Press release
Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
